Discover 1,437 paid clinical trials in New Braunfels, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,437
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Austin TX, Round Rock TX, Waco TX, Sugar Land TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07144280
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
for
CRC (Colorectal Cancer)
Location: Austin TX, Houston TX, Springfield MO, Rio Rancho NM,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07284849
Phase 3, Recruiting
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
for
Colon Cancer, Rectal Cancer, Colorectal Cancer,
Location: Austin TX, Beaumont TX, Tyler TX, Columbia MO,
Sponsor: SCRI Development Innovations, LLC
Sex: All
Age: 18+
Code: NCT07011576
Phase 2, Recruiting
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
for
Follicular Lymphoma
Location: Austin TX, Tyler TX, Hattiesburg MS, Mobile AL,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT06911502
Phase 3, Recruiting
Impact of CBD-Rich Oil on Aversive Memory Reconsolidation
for
Anxiety and Fear
Location: Austin TX
Sponsor: University of Texas at Austin
Sex: All
Age: 18 - 65
Code: NCT04726475
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
for
HPV
Location: Austin TX, Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06109870
Recruiting
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Austin TX, Houston TX, New Orleans LA, Orlando FL,
Sponsor: Nuvation Bio Inc.
Sex: All
Age: 18+
Code: NCT07154706
Phase 3, Recruiting
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
for
Polymyositis, Dermatomyositis
Location: Austin TX, Colleyville TX, North Richland Hills TX,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06455449
Phase 3, Recruiting
A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
for
Non Small Cell Lung Cancer
Location: Austin TX, Weston FL, Detroit MI, Cleveland OH,
Sponsor: Wayshine Biopharm, Inc.
Sex: All
Age: 18+
Code: NCT06868485
Phase 2, Recruiting
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
for
Immune Thrombocytopenia (ITP)
Location: Austin TX, The Woodlands TX, Houston TX, New Orleans LA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06721013
Phase 1, Phase 2, Recruiting
A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)
for
Squamous Non-small Cell Lung Cancer
Location: Austin TX, St Louis MO, Nashville TN, Tampa FL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07221474
Phase 2, Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
for
Chronic Lymphocytic Leukemia (CLL),
Location: Austin TX, Nashville TN, Denver CO, Phoenix AZ,
Sponsor: Nurix Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07221500
Phase 2, Recruiting
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
for
Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC),